Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESIST 2: Tipranavir/Ritonavir vs Comparator PI/Ritonavir in Experienced HIV Patients
NCT00144170Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Feb 2003
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 17
01
Overview
A Phase 3 trial of tipranavir in human immunodeficiency virus infection (HIV), sponsored by Boehringer Ingelheim. Started Feb 2003; status: completed.
02
Drugs
tipranavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00144170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00144170.